Simultaneous transarterial chemoembolization combined with radiofrequency ablation for treatment of large hepatocellular carcinoma: 3 years follow-up

Duan Feng; Bai Yan-Hua; Cui Li; Li Xiao-Hui; Yan Jie-Yu

doi:10.18632/oncotarget.23988

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/02/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Clinical Research Papers:

Simultaneous transarterial chemoembolization combined with radiofrequency ablation for treatment of large hepatocellular carcinoma: 3 years follow-up

Duan Feng _, Bai Yan-Hua, Cui Li, Li Xiao-Hui and Yan Jie-Yu

Duan Feng1, Bai Yan-Hua1, Cui Li1, Li Xiao-Hui1 and Yan Jie-Yu1

1Department of Interventional Radiology, The General Hospital of Chinese People’s Liberation Army, Beijing 100853, China

Correspondence to:

Duan Feng, email: [email protected]

Keywords: chemoembolization; radiofrequency; hepatocellular carcinoma; simultaneous combination

Received: August 21, 2017 Accepted: November 16, 2017 Epub: January 02, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23988

Publication Alerts

Withdrawal Notice

Clinical Research Papers:

Simultaneous transarterial chemoembolization combined with radiofrequency ablation for treatment of large hepatocellular carcinoma: 3 years follow-up